468 related articles for article (PubMed ID: 24607601)
1. Generation of improved humanized mouse models for human infectious diseases.
Brehm MA; Wiles MV; Greiner DL; Shultz LD
J Immunol Methods; 2014 Aug; 410():3-17. PubMed ID: 24607601
[TBL] [Abstract][Full Text] [Related]
2. Overcoming current limitations in humanized mouse research.
Brehm MA; Shultz LD; Luban J; Greiner DL
J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S125-30. PubMed ID: 24151318
[TBL] [Abstract][Full Text] [Related]
3. The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.
Berges BK; Rowan MR
Retrovirology; 2011 Aug; 8():65. PubMed ID: 21835012
[TBL] [Abstract][Full Text] [Related]
4. Novel Humanized Peripheral Blood Mononuclear Cell Mouse Model with Delayed Onset of Graft-versus-Host Disease for Preclinical HIV Research.
Holguin L; Echavarria L; Burnett JC
J Virol; 2022 Feb; 96(3):e0139421. PubMed ID: 34818071
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
6. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.
Zhang L; Meissner E; Chen J; Su L
Sci China Life Sci; 2010 Feb; 53(2):195-203. PubMed ID: 20596827
[TBL] [Abstract][Full Text] [Related]
7. Humanized Mouse Models of Clinical Disease.
Walsh NC; Kenney LL; Jangalwe S; Aryee KE; Greiner DL; Brehm MA; Shultz LD
Annu Rev Pathol; 2017 Jan; 12():187-215. PubMed ID: 27959627
[TBL] [Abstract][Full Text] [Related]
8. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.
Akkina R; Allam A; Balazs AB; Blankson JN; Burnett JC; Casares S; Garcia JV; Hasenkrug KJ; Kashanchi F; Kitchen SG; Klein F; Kumar P; Luster AD; Poluektova LY; Rao M; Sanders-Beer BE; Shultz LD; Zack JA
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):109-19. PubMed ID: 26670361
[TBL] [Abstract][Full Text] [Related]
9. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
[TBL] [Abstract][Full Text] [Related]
10. Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies.
Agarwal Y; Beatty C; Biradar S; Castronova I; Ho S; Melody K; Bility MT
Retrovirology; 2020 Apr; 17(1):8. PubMed ID: 32276640
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 immunopathogenesis in humanized mouse models.
Zhang L; Su L
Cell Mol Immunol; 2012 May; 9(3):237-44. PubMed ID: 22504952
[TBL] [Abstract][Full Text] [Related]
12. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
13. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection.
Dagur RS; Branch-Woods A; Mathews S; Joshi PS; Quadros RM; Harms DW; Cheng Y; Miles SM; Pirruccello SJ; Gurumurthy CB; Gorantla S; Poluektova LY
BMC Immunol; 2019 Jan; 20(1):2. PubMed ID: 30616506
[TBL] [Abstract][Full Text] [Related]
14. Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.
Covassin L; Jangalwe S; Jouvet N; Laning J; Burzenski L; Shultz LD; Brehm MA
Clin Exp Immunol; 2013 Dec; 174(3):372-88. PubMed ID: 23869841
[TBL] [Abstract][Full Text] [Related]
15. Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells.
Hasgur S; Aryee KE; Shultz LD; Greiner DL; Brehm MA
Methods Mol Biol; 2016; 1438():67-78. PubMed ID: 27150084
[TBL] [Abstract][Full Text] [Related]
16. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses.
Singh M; Singh P; Gaudray G; Musumeci L; Thielen C; Vaira D; Vandergeeten C; Delacroix L; Van Gulck E; Vanham G; de Leval L; Rahmouni S; Moutschen M
PLoS One; 2012; 7(6):e38491. PubMed ID: 22675567
[TBL] [Abstract][Full Text] [Related]
17. Humanized mouse models to study human diseases.
Brehm MA; Shultz LD; Greiner DL
Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):120-5. PubMed ID: 20150806
[TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.
Olesen R; Wahl A; Denton PW; Garcia JV
J Reprod Immunol; 2011 Mar; 88(2):195-203. PubMed ID: 21256601
[TBL] [Abstract][Full Text] [Related]
19. Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.
Claiborne DT; Dudek TE; Maldini CR; Power KA; Ghebremichael M; Seung E; Mellors EF; Vrbanac VD; Krupp K; Bisesi A; Tager AM; Knipe DM; Boutwell CL; Allen TM
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375576
[TBL] [Abstract][Full Text] [Related]
20. [Development of the next generation humanized mouse for drug discovery].
Ito R
Nihon Yakurigaku Zasshi; 2018; 151(4):160-165. PubMed ID: 29628464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
